Ben Urick, PharmD, PhD
Vanita Rahman, MD, DipABLM
Ted Barnett, MD, FACLM
This presentation will review the indications for GLP-1 therapies to treat obesity in patients without diabetes. Use of these products is associated with side effects and adverse events, and improvements in clinical outcomes and medical cost offsets are not observed through medical claims analysis within two years of initiation. Learn from experts who discuss the pros and cons of GLP-1 medications for patients struggling with weight management.
Read more